Immunome, Inc. (IMNM)
- Previous Close
15.28 - Open
15.32 - Bid 15.23 x 600
- Ask 15.44 x 300
- Day's Range
15.19 - 15.65 - 52 Week Range
4.44 - 30.96 - Volume
258,468 - Avg. Volume
793,495 - Market Cap (intraday)
913.918M - Beta (5Y Monthly) 1.66
- PE Ratio (TTM)
-- - EPS (TTM)
-5.38 - Earnings Date May 3, 2024 - May 7, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
35.33
Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consist of IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates, as well as IM-3050, a fibroblast activation protein targeted radioligand therapy; and IM-4320, an anti-IL-38 immunotherapy candidate. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
immunome.comRecent News: IMNM
Performance Overview: IMNM
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMNM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMNM
Valuation Measures
Market Cap
912.13M
Enterprise Value
771.63M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
21.63
Price/Book (mrq)
7.61
Enterprise Value/Revenue
55.05
Enterprise Value/EBITDA
-27.56
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-20.81%
Return on Equity (ttm)
-156.45%
Revenue (ttm)
14.02M
Net Income Avi to Common (ttm)
-106.81M
Diluted EPS (ttm)
-5.38
Balance Sheet and Cash Flow
Total Cash (mrq)
142.15M
Total Debt/Equity (mrq)
1.38%
Levered Free Cash Flow (ttm)
2.36M
Research Analysis: IMNM
Company Insights: IMNM
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: IMNM
Daily – Vickers Top Insider Picks for 08/24/2021
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 08/23/2021
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 08/20/2021
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 08/19/2021
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.